Drug Profile
Genopep - Issar Pharma
Alternative Names: GNP; XylentraLatest Information Update: 03 Apr 2023
Price :
$50
*
At a glance
- Originator Issar Pharma
- Class Anti-infectives; Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Burn infections; Wound infections
Most Recent Events
- 31 Mar 2023 Launched for Burn infections in India (Topical) (Issar Pharmaceuticals website, March 2023)
- 31 Mar 2023 Launched for Wound infections in India (Topical) (Issar Pharmaceuticals website, March 2023)
- 31 Mar 2023 Registered for Burn infections in India (Topical)